{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:56:37Z","timestamp":1777485397692,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and objective<\/jats:title>\n                <jats:p>Rhabdomyolysis (RM) is a life-threatening adverse drug reaction in which statins are the one commonly related to RM. The study aimed to explore the association between statin used and RM or other muscular related adverse events. In addition, drug interaction with statins were also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All extracted prescriptions were grouped as lipophilic and hydrophilic statins. RM outcome was identified by electronically screening and later ascertaining by chart review. The study proposed 4 models, i.e., logistic regression (LR), Bayesian network (BN), random forests (RF), and extreme gradient boosting (XGBoost). Features were selected using multiple processes, i.e., bootstrapping, expert opinions, and univariate analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 939 patients who used statins were identified consisting 15, 9, and 19 per 10,000 persons for overall outcome prevalence, using statin alone, and co-administrations, respectively. Common statins were simvastatin, atorvastatin, and rosuvastatin. The proposed models had high sensitivity, i.e., 0.85, 0.90, 0.95 and 0.95 for LR, BN, RF, and XGBoost, respectively. The area under the receiver operating characteristic was significantly higher in LR than BN, i.e., 0.80 (0.79, 0.81) and 0.73 (0.72, 0.74), but a little lower than the RF [0.817 (95% CI 0.811, 0.824)] and XGBoost [0.819 (95% CI 0.812, 0.825)]. The LR model indicated that a combination of high-dose lipophilic statin, clarithromycin, and antifungals was 16.22 (1.78, 148.23) times higher odds of RM than taking high-dose lipophilic statin alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study suggested that statin uses may have drug interactions with others including clarithromycin and antifungal drugs in inducing RM. A prospective evaluation of the model should be further assessed with well planned data monitoring. Applying LR in hospital system might be useful in warning drug interaction during prescribing.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-022-01978-4","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T17:02:38Z","timestamp":1662397358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Detection of statin-induced rhabdomyolysis and muscular related adverse events through data mining technique"],"prefix":"10.1186","volume":"22","author":[{"given":"Patratorn","family":"Kunakorntham","sequence":"first","affiliation":[]},{"given":"Oraluck","family":"Pattanaprateep","sequence":"additional","affiliation":[]},{"given":"Charungthai","family":"Dejthevaporn","sequence":"additional","affiliation":[]},{"given":"Ratchainant","family":"Thammasudjarit","sequence":"additional","affiliation":[]},{"given":"Ammarin","family":"Thakkinstian","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"issue":"1","key":"1978_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-016-1314-5","volume":"20","author":"LO Chavez","year":"2016","unstructured":"Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016;20(1):135.","journal-title":"Crit Care"},{"key":"1978_CR2","doi-asserted-by":"crossref","unstructured":"Stahl K, Rastelli E, Schoser B. A systematic review on the definition of rhabdomyolysis. J Neurol. 2019.","DOI":"10.1055\/s-0039-1685054"},{"issue":"1","key":"1978_CR3","first-page":"58","volume":"15","author":"PA Torres","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015;15(1):58\u201369.","journal-title":"Ochsner J"},{"issue":"8","key":"1978_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2169\/internalmedicine.50.4484","volume":"50","author":"Y Oshima","year":"2011","unstructured":"Oshima Y. Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration. Intern Med. 2011;50(8):845\u201353.","journal-title":"Intern Med"},{"issue":"12","key":"1978_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2012.12.034","volume":"61","author":"KF Erickson","year":"2013","unstructured":"Erickson KF, Japa S, Owens DK, Chertow GM, Garber AM, Goldhaber-Fiebert JD. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013;61(12):1250\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1978_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000475607","volume":"137","author":"SA Silver","year":"2017","unstructured":"Silver SA, Chertow GM. The economic consequences of acute kidney injury. Nephron. 2017;137(4):297\u2013301.","journal-title":"Nephron"},{"issue":"8","key":"1978_CR7","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.clinthera.2007.08.022","volume":"29","author":"GA Nichols","year":"2007","unstructured":"Nichols GA, Koro CE. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Clin Ther. 2007;29(8):1761\u201370.","journal-title":"Clin Ther"},{"issue":"21","key":"1978_CR8","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","volume":"292","author":"DJ Graham","year":"2004","unstructured":"Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004;292(21):2585\u201390.","journal-title":"JAMA"},{"issue":"4 Suppl 3","key":"1978_CR9","doi-asserted-by":"publisher","first-page":"III32","DOI":"10.1002\/clc.4960261507","volume":"26","author":"JM McKenney","year":"2003","unstructured":"McKenney JM. Pharmacologic characteristics of statins. Clin Cardiol. 2003;26(4 Suppl 3):III32\u20138.","journal-title":"Clin Cardiol"},{"issue":"4","key":"1978_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4103\/0976-500X.103687","volume":"3","author":"MS Doshi","year":"2012","unstructured":"Doshi MS, Patel PP, Shah SP, Dikshit RK. Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital. J Pharmacol Pharmacother. 2012;3(4):308\u201313.","journal-title":"J Pharmacol Pharmacother"},{"issue":"6","key":"1978_CR11","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/clpt.2012.50","volume":"91","author":"R Harpaz","year":"2012","unstructured":"Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012;91(6):1010\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"1978_CR12","unstructured":"European Medicines Agency. EMA\/849944\/2016-Screening for adverse reactions in EudraVigilance 2016 [July 5, 2019]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/other\/screening-adverse-reactions-eudravigilance_en.pdf."},{"key":"1978_CR13","unstructured":"U.S. Food and Drug Administration. Data Mining at FDA -- White Paper 2018 [July 5, 2019]. Available from: https:\/\/www.fda.gov\/science-research\/data-mining-fda\/data-mining-fda-white-paper#methods."},{"issue":"4","key":"1978_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54(4):315\u201321.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"1978_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40264-014-0204-5","volume":"37","author":"O Caster","year":"2014","unstructured":"Caster O, Juhlin K, Watson S, Noren GN. Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank. Drug Saf. 2014;37(8):617\u201328.","journal-title":"Drug Saf"},{"issue":"3","key":"1978_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/amiajnl-2012-000930","volume":"20","author":"R Harpaz","year":"2013","unstructured":"Harpaz R, Vilar S, Dumouchel W, Salmasian H, Haerian K, Shah NH, et al. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J Am Med Inform Assoc JAMIA. 2013;20(3):413\u20139.","journal-title":"J Am Med Inform Assoc JAMIA"},{"issue":"2","key":"1978_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/amiajnl-2013-001612","volume":"21","author":"SV Iyer","year":"2014","unstructured":"Iyer SV, Harpaz R, LePendu P, Bauer-Mehren A, Shah NH. Mining clinical text for signals of adverse drug-drug interactions. J Am Med Inform Assoc JAMIA. 2014;21(2):353\u201362.","journal-title":"J Am Med Inform Assoc JAMIA"},{"issue":"5","key":"1978_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/cpt.526","volume":"101","author":"SL Chan","year":"2017","unstructured":"Chan SL, Tham MY, Tan SH, Loke C, Foo B, Fan Y, et al. Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records. Clin Pharmacol Ther. 2017;101(5):667\u201374.","journal-title":"Clin Pharmacol Ther"},{"key":"1978_CR19","doi-asserted-by":"crossref","unstructured":"Liu M, Matheny M, Hu Y, Xu H. Data mining methodologies for pharmacovigilance. 2012. 35\u201342 p.","DOI":"10.1145\/2408736.2408742"},{"key":"1978_CR20","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2019 2019 [August 22, 2019]. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"key":"1978_CR21","unstructured":"Abimbola Farinde P, PhD. Laboratory Reference Ranges in Healthy Adults 2019 [updated May 14, 2019May 2, 2020]. Available from: https:\/\/emedicine.medscape.com\/article\/2172316-overview."},{"key":"1978_CR22","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019."},{"issue":"1","key":"1978_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","volume":"20","author":"MJ Azur","year":"2011","unstructured":"Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res. 2011;20(1):40\u20139.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"2","key":"1978_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","volume":"42","author":"H-Y Kim","year":"2017","unstructured":"Kim H-Y. Statistical notes for clinical researchers: Chi-squared test and Fisher\u2019s exact test. Restor Dent Endod. 2017;42(2):152\u20135.","journal-title":"Restor Dent Endod"},{"key":"1978_CR25","unstructured":"Kraisangka J, Druzdzel MJ. Making large Cox\u2019s proportional hazard models tractable in Bayesian networks. In: Alessandro A, Giorgio C, Cassio Polpo C, editors. Proceedings of the eighth international conference on probabilistic graphical models; Proceedings of Machine Learning Research: PMLR; 2016. p. 252\u201363."},{"key":"1978_CR26","unstructured":"Szczygie\u0142 J, Oni\u015bko A, \u015awiderska J, Krysiewicz E, Sienkiewicz J. Probabilistic graphical model supporting early diagnosis of autism spectrum disorder. Adv Comput Sci Res. 2014."},{"issue":"4","key":"1978_CR27","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1177\/0363546520988021","volume":"49","author":"PN Ramkumar","year":"2021","unstructured":"Ramkumar PN, Karnuta JM, Haeberle HS, Owusu-Akyaw KA, Warner TS, Rodeo SA, et al. Association between preoperative mental health and clinically meaningful outcomes after osteochondral allograft for cartilage defects of the knee: a machine learning analysis. Am J Sports Med. 2021;49(4):948\u201357.","journal-title":"Am J Sports Med"},{"issue":"1","key":"1978_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, et al. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2(1):56\u201367.","journal-title":"Nat Mach Intell"},{"key":"1978_CR29","unstructured":"Lundberg SM, Erion GG, Lee S-IJae-p. Consistent individualized feature attribution for tree ensembles2018 February 01, 2018: [arXiv:1802.03888]."},{"issue":"27(2)","key":"1978_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"30","author":"MJDARS Pencina","year":"2008","unstructured":"Pencina MJDARS, D\u2019Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;30(27(2)):157\u201372.","journal-title":"Stat Med"},{"issue":"12","key":"1978_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.12691\/ajmcr-7-12-9","volume":"7","author":"PT Kariyanna","year":"2019","unstructured":"Kariyanna PT, Haseeb S, Chowdhury YS, Jayarangaiah A, Maryniak A, Mo G, et al. Ticagrelor and statin interaction induces rhabdomyolysis and acute renal failure: case reports and scoping review. Am J Med Case Rep. 2019;7(12):337\u201341.","journal-title":"Am J Med Case Rep"},{"issue":"23_suppl_1","key":"1978_CR32","doi-asserted-by":"publisher","first-page":"III-50","DOI":"10.1161\/01.CIR.0000131519.15067.1f","volume":"109","author":"S Bellosta","year":"2004","unstructured":"Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation. 2004;109(23_suppl_1):III-50\u2013III\u22127.","journal-title":"Circulation"},{"issue":"21","key":"1978_CR33","first-page":"e468","volume":"134","author":"S Wiggins Barbara","year":"2016","unstructured":"Wiggins Barbara S, Saseen Joseph J, Page Robert L, Reed Brent N, Sneed K, Kostis John B, et al. Recommendations for management of clinically significant drug\u2013drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2016;134(21):e468\u201395.","journal-title":"Circulation"},{"issue":"3","key":"1978_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s002280000127","volume":"56","author":"T Kantola","year":"2000","unstructured":"Kantola T, Backman JT, Niemi M, Kivisto KT, Neuvonen PJ. Effect of fluconazole on plasma fluvastatin and pravastatin concentrations. Eur J Clin Pharmacol. 2000;56(3):225\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"1978_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-319-19425-7_5","volume-title":"Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis","author":"FE Harrell","year":"2015","unstructured":"Harrell FE. Describing, resampling, validating, and simplifying the model. In: Harrell JFE, editor. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Cham: Springer; 2015. p. 103\u201326."},{"key":"1978_CR36","first-page":"239","volume":"7","author":"H Mannan","year":"2017","unstructured":"Mannan H. A practical application of a simple bootstrapping method for assessing predictors selected for epidemiologic risk models using automated variable selection. Int J Stat Appl. 2017;7:239\u201349.","journal-title":"Int J Stat Appl"},{"issue":"1","key":"1978_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0587.2012.07348.x","volume":"36","author":"CF Dormann","year":"2013","unstructured":"Dormann CF, Elith J, Bacher S, Buchmann C, Carl G, Carr\u00e9 G, et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography. 2013;36(1):27\u201346.","journal-title":"Ecography"},{"issue":"3","key":"1978_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","volume":"40","author":"RC Pasternak","year":"2002","unstructured":"Pasternak RC, Smith SC, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40(3):567\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"1978_CR39","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","volume":"36","author":"ES Stroes","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment. Aetiol Manag Eur Heart J. 2015;36(17):1012\u201322.","journal-title":"Aetiol Manag Eur Heart J"},{"key":"1978_CR40","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2147\/TCRM.S214938","volume":"15","author":"A Abu Mellal","year":"2019","unstructured":"Abu Mellal A, Hussain N, Said AS. The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies. Ther Clin Risk Manag. 2019;15:921\u201336.","journal-title":"Ther Clin Risk Manag"},{"key":"1978_CR41","doi-asserted-by":"crossref","unstructured":"Dybro AM, Damkier P, Rasmussen TB, Hellfritzsch M. Statin-associated rhabdomyolysis triggered by drug\u2013drug interaction with itraconazole. BMJ Case Rep. 2016;2016:bcr2016216457.","DOI":"10.1136\/bcr-2016-216457"},{"issue":"9","key":"1978_CR42","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1345\/aph.10228","volume":"35","author":"MA Omar","year":"2001","unstructured":"Omar MA, Wilson JP, Cox TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother. 2001;35(9):1096\u2013107.","journal-title":"Ann Pharmacother"},{"key":"1978_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JTS.1000181","volume":"3","author":"K Eljaaly","year":"2017","unstructured":"Eljaaly K, Alshehri S. An updated review of interactions of statins with antibacterial and antifungal agents. J Transl Sci. 2017;3:1\u20134.","journal-title":"J Transl Sci"},{"issue":"11","key":"1978_CR44","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jclinepi.2003.05.003","volume":"57","author":"KJ Ottenbacher","year":"2004","unstructured":"Ottenbacher KJ, Ottenbacher HR, Tooth L, Ostir GV. A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions. J Clin Epidemiol. 2004;57(11):1147\u201352.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-01978-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T17:05:48Z","timestamp":1662397548000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-01978-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-01978-4","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Ramathibodi Hospital (COA. MURA2019\/1083). All the methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki), and informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}